These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 728214)

  • 1. Hypolipidemic effect of alpha-mono-p-myristyloxy-alpha'-methylcinnamoyl glycerol (LK-903) in rats.
    Takashima K; Ohyama K; Mori T; Takeyama S
    Biochem Pharmacol; 1978; 27(22):2631-5. PubMed ID: 728214
    [No Abstract]   [Full Text] [Related]  

  • 2. Antilipolytic effect of p-myristyloxy-alpha-methylcinnamic acid (LK-903 acid) as a mechanism of the hypolipidemic action of its alpha-monoglyceride (LK-903).
    Takashima K; Takeyama S
    Biochem Pharmacol; 1978; 27(22):2637-9. PubMed ID: 728215
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphatic absorption of hypolipidemic compound, 1-O-[p-(myristyloxy)-alpha-methylcinnamoyl] glycerol (LK-903).
    Sugihara J; Furuuchi S
    J Pharmacobiodyn; 1988 Feb; 11(2):121-30. PubMed ID: 3379564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic applications of Baylis-Hillman chemistry: an efficient and solely stereoselective synthesis of (E)-alpha-methylcinnamic acids and potent hypolipidemic agent LK-903 from unmodified Baylis-Hillman adducts.
    Das B; Banerjee J; Chowdhury N; Majhi A
    Chem Pharm Bull (Tokyo); 2006 Dec; 54(12):1725-7. PubMed ID: 17139111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of peroxisomal enzymes in rat liver by the hypolipidemic agent LK-903.
    Hayashi H; Hino S; Yamasaki F; Watanabe T; Suga T
    Biochem Pharmacol; 1981 Jul; 30(13):1817-22. PubMed ID: 7271869
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypocholesterolemic activities of LK-903 and clofibrate in miniature pigs, cynomolgus monkeys and beagle dogs.
    Takashima K; Mori T; Ohyama K; Nitta S; Takeyama S
    Chem Pharm Bull (Tokyo); 1978 Aug; 26(8):2454-7. PubMed ID: 101309
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of hypolipidemic agents. 1. Synthesis and hypolipidemic activities of alkoxycinnamic acid derivatives.
    Watanabe T; Hayashi K; Yoshimatsu S; Sakai K; Takeyama S; Takashima K
    J Med Chem; 1980 Jan; 23(1):50-9. PubMed ID: 7359513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic effect of clofibrate and fatty acid oxidation in peroxisomes.
    Nutr Rev; 1977 Apr; 35(4):74-5. PubMed ID: 323754
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
    Elwood JC; Richert DA; Westerfeld WW
    Biochem Pharmacol; 1972 Apr; 21(8):1127-34. PubMed ID: 5034198
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats.
    Goto H; Yamashita S; Makita T
    Exp Anim; 1998 Oct; 47(4):257-60. PubMed ID: 10067169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
    Seki K; Fukuda M; Isegawa J; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
    Maier R; Muller K
    Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
    Orton TC; Parker GL
    Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
    Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
    Berge RK; Bakke OM
    Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of clofibrate on blood and tissue lipids in rats on a normal and on a cholesterol-enriched diet].
    Decoopman E; Dewailly P; Fruchart JC; Jaillard J; Sezille G
    Lille Med; 1977 Mar; 22(3):158-63, 193. PubMed ID: 853857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
    Rousselet F; Fredj G; Clenet M
    Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the metabolism of lipids caused by administration of cinarine].
    Antona A; Palazzoadriano M; Tusa C
    Clin Ter; 1971 Jul; 58(2):109-16. PubMed ID: 5157281
    [No Abstract]   [Full Text] [Related]  

  • 19. Antilipolytic effect of tiadenol and clofibrate in rat epididymal fat pads.
    Bacciarelli C; Boni P; Castellucci A
    Farmaco Prat; 1978 Sep; 33(9):401-6. PubMed ID: 218836
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenobarbital on lipid peroxidation in the liver.
    Hahn HK; Tuma DJ; Barak AJ; Sorrell MF
    Biochem Pharmacol; 1976 Apr; 25(7):769-72. PubMed ID: 820355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.